CIK 0001326190
- Non-accelerated filer
- Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 202726770
- Phone
- +1 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- Open-market buys, last 90 days
- $82,244
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$82,244. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-12-09 | PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 10% owner | Sale | −436,324 | $3.26 | $1.4M | 6,626,403 |
| 2016-12-08 | PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 10% owner | Sale | −440,479 | $3.25 | $1.4M | 7,062,727 |
| 2016-12-07 | PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 10% owner | Sale | −477,829 | $3.26 | $1.6M | 7,503,206 |
| 2016-11-28 | Runge Jeffrey W. Director | Option exercise | +20,000 | $2.20 | $44K | 177,700 |
| 2016-11-28 | Runge Jeffrey W. Director | Option exercise · Stock Option (right to buy) | −20,000 | 0 | ||
| 2016-11-22 | GILL JOHN President and CEO | Option exercise | +100,000 | $2.20 | $220K | 822,244 |
| 2016-11-22 | GILL JOHN President and CEO | Option exercise · Employee Stock Option (right to buy) | −100,000 | 0 | ||
| 2016-11-22 | SAYARE MITCHEL Director | Option exercise | +20,000 | $1.52 | $30K | 25,000 |
| 2016-11-22 | SAYARE MITCHEL Director | Option exercise | +20,000 | $1.60 | $32K | 45,000 |
| 2016-11-22 | SAYARE MITCHEL Director | Option exercise | +60,000 | $2.67 | $160K | 105,000 |
| 2016-11-22 | SAYARE MITCHEL Director | Option exercise | +52,139 | $2.67 | $139K | 157,139 |
| 2016-11-22 | SAYARE MITCHEL Director | Option exercise | +20,000 | $1.45 | $29K | 177,139 |
| 2016-11-22 | SAYARE MITCHEL Director | Option exercise | +20,000 | $1.64 | $33K | 197,139 |
| 2016-11-22 | SAYARE MITCHEL Director | Option exercise | +20,000 | $1.51 | $30K | 217,139 |
| 2016-11-22 | SAYARE MITCHEL Director | Option exercise | +18,361 | $1.81 | $33K | 235,500 |
| 2016-11-22 | SAYARE MITCHEL Director | Option exercise | +20,000 | $1.69 | $34K | 255,500 |
| 2016-11-22 | SAYARE MITCHEL Director | Option exercise | +20,000 | $2.20 | $44K | 275,500 |
| 2016-11-22 | SAYARE MITCHEL Director | Option exercise · Stock option (right to buy) | −20,000 | 0 | ||
| 2016-11-22 | SAYARE MITCHEL Director | Option exercise · Stock option (right to buy) | −20,000 | 0 | ||
| 2016-11-22 | SAYARE MITCHEL Director | Option exercise · Stock option (right to buy) | −60,000 | 0 |
Page 34 of 43 · 845 trades